These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12708738)

  • 1. Single dose ROM therapy in Goa.
    Shukla P; Miranda MS; Prabhudesai R; Rege VL
    Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 3. Single dose multidrug therapy for single lesion paucibacillry leprosy.
    Salafia A
    Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 8. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Kars HK
    Indian J Lepr; 1998; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
    [No Abstract]   [Full Text] [Related]  

  • 10. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Prasad KN
    Indian J Lepr; 1998; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A; Khopkar U; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract]   [Full Text] [Related]  

  • 12. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D
    Indian J Lepr; 1998; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
    Ramu G
    Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations.
    Revankar CR; Bulchand HO; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):37-8. PubMed ID: 12120040
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
    Deshmukh AR; Dhurat RS; Jerajani HR
    Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose 'ROM' therapy--is it really effective?
    Mandal AK
    Natl Med J India; 1998; 11(5):247. PubMed ID: 10997176
    [No Abstract]   [Full Text] [Related]  

  • 17. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
    Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group
    Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
    Lockwood DN; Cunha Mda G
    Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.